RDMD Revenue and Competitors

Location

$67.1M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • RDMD's estimated annual revenue is currently $2.6M per year.(i)
  • RDMD's estimated revenue per employee is $77,500
  • RDMD's total funding is $67.1M.

Employee Data

  • RDMD has 34 Employees.(i)
  • RDMD grew their employee count by -64% last year.

RDMD's People

NameTitleEmail/Phone
1
Co-founder, CEOReveal Email/Phone
2
Head EngineeringReveal Email/Phone
3
Clinical Abstraction LeadReveal Email/Phone
4
Software EngineerReveal Email/Phone
5
Clinical Information AssociateReveal Email/Phone
6
Software EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is RDMD?

RDMD's mission is to empower patients and communities to accelerate the development of treatments for rare diseases of all kinds. We are a medical data science company that helps to identify patients and generate regulatory-grade evidence to enable drug approvals and real world evidence in rare disease. RDMD is privately funded by Lux Capital and Village Global, a venture capital firm with a network of LPs including Reid Hoffman, Bill Gates, Mark Zuckerberg, and Jeff Bezos. Read about our mission at www.rdmd.com

keywords:N/A

$67.1M

Total Funding

34

Number of Employees

$2.6M

Revenue (est)

-64%

Employee Growth %

N/A

Valuation

N/A

Accelerator

RDMD News

2020-04-18 - Daily funding roundup - April 17th, 2020

Gembah raised $3.3M; Learn In secured $3.5M; Everee picks up $10M; RDMD landed $14M Gembah: Gembah is a product development platform. Gembah has raised $3.3 million in seed funding led by Silverton Partners, with participation from ATX Venture Partners and Capital Factory. Read more. Learn In: ...

2020-04-16 - RDMD Secures $14M in Series A Financing

RDMD, a San Francisco, CA-based healthcare technology company focused on accelerating drug research for patients with rare diseases, raised $14m in Series A financing. The round was led by Spark Capital, with participation from existing seed investors Lux Capital, Village Global and Garuda Vent ...

2018-08-21 - Lux Capital Leads $3M Seed Funding for RDMD

SAN FRANCISCO--(BUSINESS WIRE)--RDMD, a healthcare technology company dedicated to accelerating research for patients with rare diseases, today announced that it has raised $3 million in seed financing. The financing was led by Lux Capital, with participation from Village Global, First Round's H ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.6M34-19%$14.2M
#2
$3.6M3417%$44M
#3
$3.9M34N/AN/A
#4
$3.6M340%$11.4M
#5
$3.8M34N/AN/A